Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants
Authors:
- 15 July 2022
- journal article
- research article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 26 (5) , 551-560
Abstract
Background and Objective Pediatric cardiomyopathies are clinically heterogeneous heart muscle disorders associated with significant morbidity and mortality for which substantial evidence for a genetic contribution was previously reported. We present a detailed molecular investigation of a cohort of 231 patients presenting with primary cardiomyopathy below the age of 18 years. Methods Cases with pediatric cardiomyopathies were analyzed using a next-generation sequencing (NGS) workflow based on a virtual panel including 57 cardiomyopathy-related genes. Results This molecular approach led to the identification of 69 cases (29.9% of the cohort) genotyped as a carrier of at least one pathogenic or likely pathogenic variant. Fourteen patients were carriers of two mutated alleles (homozygous or compound heterozygous) on the same cardiomyopathy-related gene, explaining the severe clinical disease with early-onset cardiomyopathy. Homozygous TNNI3 pathogenic variants were detected for five unrelated neonates (2.2% of the cohort), with four of them carrying the same truncating variant, i.e. p.Arg69Alafs*8. Conclusions Our study confirmed the importance of genetic testing in pediatric cardiomyopathies. Discovery of novel pathogenic variations is crucial for clinical management of affected families, as a positive genetic result might be used by a prospective parent for prenatal genetic testing or in the process of pre-implantation genetic diagnosis.Keywords
This publication has 35 references indexed in Scilit:
- Atlas of the clinical genetics of human dilated cardiomyopathyEuropean Heart Journal, 2014
- Characterization of a Phenotype-Based Genetic Test Prediction Score for Unrelated Patients With Hypertrophic CardiomyopathyMayo Clinic Proceedings, 2014
- Dilated cardiomyopathy: the complexity of a diverse genetic architectureNature Reviews Cardiology, 2013
- Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene MutationsJACC, 2011
- Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathyNetherlands Heart Journal, 2011
- Deletion in TNNI3 gene is associated with restrictive cardiomyopathyInternational Journal of Cardiology, 2009
- Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic CardiomyopathyMayo Clinic Proceedings, 2008
- Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genesHeart, 2008
- Deletion in the Cardiac Troponin I Gene in a Family From Northern Sweden with Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young AdultsCirculation, 1995